GI
Market Cap
N/A
All Drugs
6
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (6 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GIM-IIT-993 | GIM-IIT-993 | NDA/BLA | 1 | PLK4 | FTD | ||
| GIM-IIT-628 | GIM-IIT-628 | Phase 2/3 | 1 | PSMA | Ewing Sarcoma | ||
| GIM-IIT-837 | GIM-IIT-837 | Phase 1 | 1 | FGFR | RSV | ||
| GIM-IIT-532 | GIM-IIT-532 | Phase 1/2 | 1 | KRASG12D | SCD | ||
| GIM-IIT-646 | GIM-IIT-646 | Phase 3 | 1 | PARP | PsA | ||
| GIM-IIT-548 | GIM-IIT-548 | Phase 3 | 1 | GIP-R | HCC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)